TY  - GEN
AU  - Leoncini,Mario
AU  - Toso,Anna
AU  - Maioli,Mauro
AU  - Angiolillo,Dominick J
AU  - Giusti,Betti
AU  - Marcucci,Rossella
AU  - Abbate,Rosanna
AU  - Bellandi,Francesco
TI  - High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study
SN  - 1876-7605
PY  - 2013///0812
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Atorvastatin
KW  - Blood Platelets
KW  - drug effects
KW  - Chi-Square Distribution
KW  - Clopidogrel
KW  - Coronary Artery Disease
KW  - blood
KW  - Cytochrome P-450 CYP2C19
KW  - Drug Interactions
KW  - Drug Resistance
KW  - Female
KW  - Heptanoic Acids
KW  - administration & dosage
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Italy
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Pharmacogenetics
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Function Tests
KW  - Prospective Studies
KW  - Purinergic P2Y Receptor Antagonists
KW  - Pyrroles
KW  - Receptors, Purinergic P2Y12
KW  - Risk Assessment
KW  - Risk Factors
KW  - Ticlopidine
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jcin.2012.09.013
ER  -